Page last updated: 2024-10-22

albendazole and Pulmonary Fibrosis

albendazole has been researched along with Pulmonary Fibrosis in 1 studies

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research Excerpts

ExcerptRelevanceReference
" Serological tests confirmed the diagnosis of pulmonary strongyloidiasis, and both patients were treated with anti-helminthic medications, including albendazole and ivermectin."3.72Pulmonary strongyloidiasis presenting as chronic bronchitis leading to interlobular septal fibrosis and cured by treatment. ( Carrick, J; Mukerjee, CM; Walker, JC; Woods, RL, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mukerjee, CM1
Carrick, J1
Walker, JC1
Woods, RL1

Other Studies

1 other study available for albendazole and Pulmonary Fibrosis

ArticleYear
Pulmonary strongyloidiasis presenting as chronic bronchitis leading to interlobular septal fibrosis and cured by treatment.
    Respirology (Carlton, Vic.), 2003, Volume: 8, Issue:4

    Topics: Aged; Albendazole; Anthelmintics; Australia; Bronchitis, Chronic; Humans; Ivermectin; Male; Pulmonar

2003